A detailed history of Wells Fargo & Company transactions in Nkarta, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,293 shares of NKTX stock, worth $57,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,293
Previous 23,448 3.6%
Holding current value
$57,088
Previous $138,000 21.01%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.52 - $8.0 $3,819 - $6,760
845 Added 3.6%
24,293 $109,000
Q2 2024

Aug 13, 2024

BUY
$5.27 - $10.82 $66,207 - $135,931
12,563 Added 115.42%
23,448 $138,000
Q1 2024

May 10, 2024

BUY
$5.59 - $15.71 $7,663 - $21,538
1,371 Added 14.41%
10,885 $117,000
Q4 2023

Feb 09, 2024

BUY
$1.31 - $6.6 $2,331 - $11,748
1,780 Added 23.02%
9,514 $62,000
Q3 2023

Nov 13, 2023

SELL
$1.39 - $2.29 $14,196 - $23,387
-10,213 Reduced 56.91%
7,734 $10,000
Q2 2023

Aug 15, 2023

BUY
$2.19 - $5.17 $11,087 - $26,175
5,063 Added 39.3%
17,947 $39,000
Q1 2023

May 12, 2023

SELL
$3.37 - $6.3 $9,928 - $18,559
-2,946 Reduced 18.61%
12,884 $45,000
Q4 2022

Feb 13, 2023

SELL
$5.14 - $14.35 $69,513 - $194,069
-13,524 Reduced 46.07%
15,830 $94,000
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $161,988 - $242,784
13,202 Added 81.74%
29,354 $386,000
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $100,248 - $250,814
12,902 Added 396.98%
16,152 $200,000
Q1 2022

May 16, 2022

SELL
$8.66 - $14.99 $26,768 - $46,334
-3,091 Reduced 48.75%
3,250 $37,000
Q4 2021

Feb 14, 2022

SELL
$12.79 - $26.88 $21,627 - $45,454
-1,691 Reduced 21.05%
6,341 $97,000
Q2 2021

Aug 16, 2021

BUY
$23.94 - $36.68 $52,835 - $80,952
2,207 Added 37.89%
8,032 $254,000
Q1 2021

May 13, 2021

SELL
$31.33 - $59.61 $286,732 - $545,550
-9,152 Reduced 61.11%
5,825 $192,000
Q4 2020

Feb 09, 2021

BUY
$27.03 - $75.62 $67,358 - $188,445
2,492 Added 19.96%
14,977 $921,000
Q3 2020

Nov 05, 2020

BUY
$23.52 - $47.9 $293,647 - $598,031
12,485 New
12,485 $376,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.